Stockreport

Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility [Seeking Alpha]

Roivant Sciences Ltd.  (ROIV) 
PDF Play 20min Summary Roivant's high valuation stems from its strong cash position, promising drug pipeline, Techbio assets, and strategic partnerships, making it a [Read more]